- Home
- CLDI vs SUGP Comparison
CLDI vs SUGP Comparison
Compare CLDI & SUGP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLDI
- SUGP
- Stock Information
- Founded
- CLDI 2014
- SUGP 1998
- Country
- CLDI United States
- SUGP Hong Kong
- Employees
- CLDI N/A
- SUGP N/A
- Industry
- CLDI Biotechnology: Biological Products (No Diagnostic Substances)
- SUGP
- Sector
- CLDI Health Care
- SUGP
- Exchange
- CLDI Nasdaq
- SUGP NYSE
- Market Cap
- CLDI 18.1M
- SUGP 20.3M
- IPO Year
- CLDI N/A
- SUGP 2024
- Fundamental
- Price
- CLDI $0.76
- SUGP $1.17
- Analyst Decision
- CLDI Strong Buy
- SUGP
- Analyst Count
- CLDI 3
- SUGP 0
- Target Price
- CLDI $16.67
- SUGP N/A
- AVG Volume (30 Days)
- CLDI 1.2M
- SUGP 499.7K
- Earning Date
- CLDI 03-14-2025
- SUGP 02-04-2025
- Dividend Yield
- CLDI N/A
- SUGP N/A
- EPS Growth
- CLDI N/A
- SUGP N/A
- EPS
- CLDI N/A
- SUGP 0.10
- Revenue
- CLDI N/A
- SUGP $20,252,232.00
- Revenue This Year
- CLDI N/A
- SUGP N/A
- Revenue Next Year
- CLDI N/A
- SUGP N/A
- P/E Ratio
- CLDI N/A
- SUGP $11.50
- Revenue Growth
- CLDI N/A
- SUGP N/A
- 52 Week Low
- CLDI $0.69
- SUGP $0.76
- 52 Week High
- CLDI $16.80
- SUGP $5.86
- Technical
- Relative Strength Index (RSI)
- CLDI 29.25
- SUGP 46.41
- Support Level
- CLDI $0.83
- SUGP $1.03
- Resistance Level
- CLDI $0.94
- SUGP $1.24
- Average True Range (ATR)
- CLDI 0.12
- SUGP 0.12
- MACD
- CLDI -0.02
- SUGP 0.02
- Stochastic Oscillator
- CLDI 9.85
- SUGP 51.85
About CLDI Calidi Biotherapeutics Inc.
Calidi Biotherapeutics Inc is a clinical stage immuno-oncology company pioneering the development and commercialization of novel, potent and efficient stem cell-based platforms for delivery and potentiation of oncolytic viruses for the treatment of cancer.
About SUGP SU GROUP HLDGS LTD
SU Group Holdings Ltd and its subsidiaries is an integrated security-related services company. The company has two reportable segments: security-related engineering services, and security guarding and screening services and related vocational training services. The company generates the majority of its revenue from the security-related engineering services segment.